Ebola Vaccine: What You Need to Know [2025]

Details

• Alternative Title:
  Ebola Vaccine: What You Need to Know [2025] [English] ; Vaccine Information Statement: Ebola Vaccine: What You Need to Know [2025]
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  A VIS or Vaccine Information Statement is a document, produced by CDC, that informs vaccine recipients – or their parents or legal representatives – about the benefits and risks of a vaccine they are receiving. All vaccine providers, public or private, are required by the National Vaccine Childhood Injury Act (NCVIA – 42 U.S.C. § 300aa-26) to give the appropriate VIS to the patient (or parent or legal representative) prior to every dose of specific vaccines. The appropriate VIS must be given prior to the vaccination, and must be given prior to each dose of a multi-dose series. It must be given regardless of the age of the recipient: from https://www.cdc.gov/vaccines/hcp/about-vis/index.html.
  
  VISs have been translated into about 40 languages. These can be found on the website of CDC's partner, https://www.immunize.org/vis/. Not every VIS has been translated into every language.
  
  Why get vaccinated? Ebola vaccine can prevent Ebola virus disease (Zaire ebolavirus).
  
  Ebola virus disease is a rare disease that most commonly affects people and nonhuman primates (such as monkeys, gorillas, and chimpanzees). Outbreaks of Ebola virus disease occur mostly on the African continent.
  
  Ebola virus spreads through direct contact with the blood, body fluids, and tissues of people or animals who are infected with the virus or who have died of Ebola virus disease.
  
  Health care workers and family and friends in close contact with people with Ebola virus disease are at the highest risk of infection. There is little risk of catching Ebola virus disease for travelers or the general public who have not cared for or been in close contact with someone infected with Ebola virus.
  
  A person can only spread Ebola virus to other people after they develop symptoms. Symptoms of Ebola virus disease may appear between 2 to 21 days after contact with the virus. Early symptoms of Ebola virus disease often include fever, aches, pain, sore throat and fatigue and progress to symptoms such as diarrhea, vomiting, unexplained hemorrhaging, and bleeding. Later, an infected person might experience symptoms of red eyes, skin rash, and hiccups.
  
  Ebola virus disease is often deadly. Recovery depends on good supportive clinical care and the patient’s immune response. Treatments that have become available in recent years are also increasing overall survival.
  
  People who survive Ebola virus disease may have health problems after they recover. The most common problems are tiredness, headaches, muscle and joint pain, eye and vision problems (such as blurry vision, pain, redness, and sensitivity to light), weight gain, stomach pain, or loss of appetite. Other health problems can also occur. In some survivors, the virus may be hiding in certain areas of the body after they recover from the disease and can cause symptoms again later.
  
  
• Subjects:
  Ebola Vaccines Ebola Vaccines / Adverse Effects Ebolavirus Hemorrhagic Fever, Ebola / Prevention & Control Vaccines
• Keywords:
  Ebola virus disease
• Series:
  Vaccine Information Statement
• Subseries:
  Ebola Vaccine
• Publisher:
  Centers for Disease Control and Prevention (CDC) (U.S.)
• Document Type:
  Text
• Genre:
  Fact Sheet ; Patient Education Handout
• Place as Subject:
  United States
• Rights:
  Public Domain
• Topic:
  Diseases & Conditions
• Location:
  North America
• Pages in Document:
  2 pdf pages
• Collection(s):
  Infectious Diseases
• Main Document Checksum:
  urn:sha-512:f7dd68a85027949365127df32d012867f28774120cb696a6c6c45a44f11f9b66f1960d6ad6c2bec7a9ee7848e2a5c41549163b2b86339f361158a5954c5335c5
• Download URL:
  https://stacks.cdc.gov/view/cdc/252993/cdc_252993_DS1.pdf
• File Type:
  [PDF - 240.00 KB ]